Percutaneous coronary intervention patients' and cardiologists' experiences of the informed consent process in Northern England : a qualitative study by Probyn, JE et al.
 1Probyn J, et al. BMJ Open 2017;7:e015127. doi:10.1136/bmjopen-2016-015127
Open Access 
AbstrAct
Objective Informed consent is central to ethical medical 
practice, but little is known about how the process 
takes place in clinical practice. Percutaneous coronary 
intervention (PCI) is a common revascularisation 
procedure. Studies report that patients overestimate 
benefits, forget the risks and are unaware of alternative 
treatments. The aim of this study was to describe PCI 
patients’ and cardiologists’ experiences of the informed 
consent process in acute care settings.
Design/setting/participants A qualitative study with 
a maximum variation sample of elective and acute PCI 
patients and cardiologists taking their consent, recruited 
from a district general hospital and tertiary centre. In-
depth interviews were conducted, and consent discussions 
were audio recorded. Data collection, coding and 
theorising occurred simultaneously.
Findings Forty-one (26 male) patients scheduled for 
elective (20) or urgent (21) PCI and 19 cardiologists 
(5 female) participated. Despite diversity in patients’ 
experiences of informed consent, elective and acute 
patients experienced a common four-stage process 
of consent. Most patients made the decision to have 
treatment at PCI referral and took a passive role in the 
discussions we recorded. They recognised cardiologists 
as experts, trusted the medical system to ‘fix’ their health 
problem and were unaware of their role in the informed 
consent process. Informed consent discussions functioned 
as a formal ‘event’,enabling cardiologists to check 
patients’ understanding and enabling patients to access 
treatment.
Conclusions The configuration of services and patients’ 
perceptions of their role in informed consent underpin a 
mismatch between legal and ethical principles of informed 
consent and current practice. The variation in patients’ 
experiences of the current place of informed consent 
in service delivery represents a missed opportunity for 
cardiologists to work in decision-making partnerships 
with patients. In light of recent changes in the law, a new 
approach to informed consent is required.
IntroductIon
Percutaneous coronary intervention (PCI) 
(also known as coronary angioplasty) 
has become one of the most common 
medical procedures worldwide.1 PCI is a 
revascularisation technique which is used 
either electively, to treat angina symptoms in 
patients with stable coronary artery disease, 
or urgently, for those with acute coronary 
syndrome.2 A key advantage of PCI is that 
when successful it improves myocardial 
perfusion without the need for coronary 
artery bypass surgery which has a prolonged 
recovery period. Serious complications are 
uncommon, but death is one of them.3
Patients are required to give informed 
consent in advance of any medical procedure. 
Informed consent constitutes good medical 
practice,4 is a universal patient right5 and 
reflects key ethical principles.6 The partner-
ship and collaboration between the doctor 
and patient in supported decision-making 
is central to this process. For consent to be 
valid it must be freely given by patients who 
are informed and deemed to have capacity. In 
being fully informed patients should under-
stand the full range of treatment options 
including the risks, benefits, alternative treat-
ments and the outcome should they decide 
to have no treatment. Although it should be 
presumed that a patient wishes to be fully 
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Research
Strengths and limitations of this study
 ► This study provides a robust, in-depth account of 
patients’ and cardiologists’ experiences of the in-
hospital informed consent process for percutaneous 
coronary intervention in England.
 ► Findings can be used to inform service improvements 
with educational interventions to support the 
comprehensive implementation of professional and 
legal frameworks in practice.
 ► Findings add a new perspective to current 
knowledge on this topic, which largely reflects an 
American viewpoint.
 ► The study focuses on the in-hospital informed 
consent process, which does not fully account for 
earlier discussions that may have occurred.
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informed about the risks and benefits, patients' specific 
information preferences should be respected and docu-
mented.7 While legal frameworks differ across countries, 
the recent judgement in Montgomery v Lanarkshire 
Health Board8 will have a significant impact on discus-
sions about risk that are both fact and case specific during 
the informed consent process. Consent conversations will 
now need to demonstrate discussion about material risk, 
that is any risk that a ‘reasonable’ person, in the patient’s 
position, would consider important in making their deci-
sion about their treatment. 7
Studies that describe PCI patients’ perceptions about 
their treatment show that they tend to overestimate the 
benefits,9–11 forget the risks and are often unaware of 
alternative treatments,9 suggesting that treatment deci-
sions may not be fully informed or that recall is poor. 
Theoretical models of the informed consent process 
acknowledge that informed consent can be perceived 
as a ‘single event’ or an ongoing ‘process’, with the 
latter perceived as being optimal.12 The ‘single event’ 
model is unlikely to foster a doctor-patient partnership 
that enables supported decision-making13 and such 
discussions often occur once the patient has already 
committed to surgery.12–14 Informed consent practice 
varies widely across hospitals and treatments,11 15 and the 
amount and quality of information provided to patients 
is inconsistent.16 The process is complex and often 
involves interactions with several health professionals. 
The features of such discussions, including how risk 
is explained, influence patients’ decision-making.17 18 
The quality of the PCI consent process is influenced by 
individual and contextual factors such as a lack of time, 
patients’ unwillingness to participate in the process and 
the expertise of participating doctors.19
In summary, we know that the PCI informed consent 
process is complex and variable and could be improved. 
To identify how we can optimise informed consent for PCI 
we need to understand the experiences of those involved, 
in the context in which the interactions take place. 
Given this gap in knowledge, the aim of this study was to 
describe PCI patients’ and cardiologists’ experiences of 
the informed consent process in acute care settings. This 
is the first qualitative study that describes patients’ and 
cardiologists’ experiences of the PCI informed consent 
process.
Methods
study design
A qualitative methodology was appropriate to explore 
how PCI informed consent took place.20 Principles of 
constructivist grounded theory were used to generate 
an understanding of the phenomenon.21 In-depth inter-
views were chosen as the most appropriate qualitative 
methods and these data were triangulated with consent 
discussions that occurred when the consent form was 
signed.
sample, setting and recruitment
Following ethical approval we planned a series of 
in-depth interviews with a maximum variation sample of 
patients and cardiologists, recruited from two centres. We 
purposefully selected sites that differed in their service 
provision to provide a diversity of participant experi-
ences; a district general hospital (<400 PCI procedures 
annually) and a tertiary PCI centre (<1900 PCI proce-
dures annually). Participant recruitment was conducted 
sequentially across sites and continued until no new 
themes were evident in the interviews. All cardiologists 
at both sites were invited to participate by a researcher 
not involved in direct care provision. All eligible patient 
participants (<18 years of age receiving PCI electively or 
urgently for non-ST elevation myocardial infarction) were 
either sent study information in advance, or approached 
by a research nurse prior to giving informed consent. 
Patient participants were recruited purposively to ensure 
maximum variation with regard to characteristics which 
may have potentially influenced their experiences: age, 
gender and elective or acute treatment.
data collection
All participating cardiologists audio recorded the 
informed consent discussion during which the consent 
form was signed, with participating patients. We then 
subsequently interviewed these patients and their cardi-
ologists, using the consent discussion as a starting point 
for the interview. Participants completed a brief ques-
tionnaire (age, gender, procedure, occupation). For 
consistency one experienced postdoctoral researcher 
(JP), with training in qualitative research methods, who 
was not involved in care provision, conducted all semi-
structured interviews between April 2014 and March 2015. 
Patients and cardiologists were interviewed in a setting of 
their choice (hospital or home–patients only) with patient 
participants interviewed up to 14 days post-PCI. Semi-
structured interview guides were developed from existing 
literature and piloted with service users and cardiologists 
(see online supplementary material 1). Patient inter-
views explored not only the experiences of the consent 
discussion that was audio recorded but also their views 
of the wider consent process. Cardiologists recorded 
informed consent discussions in the clinical setting; 
consent forms were signed at this time. All interviews were 
audio recorded and professionally transcribed verbatim. 
Field notes and memos were recorded after each inter-
view, including initial observations and reflections about 
emerging codes and concepts. These data informed the 
initial coding. Data analysis and participant recruitment 
took place simultaneously,  to allow for the exploration of 
emerging concepts in keeping with constant comparison 
methodology.22 A group of five cardiology service users 
provided feedback on the findings.
data analysis
Data analysis was conducted by JP, FA and JG. During 
this process transcripts were independently read and 
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Table 1 Participant characteristics
Characteristics n (%)
Elective patients (SCAD)
  Participants 20 (49)
  Male (% elective patients) 12 (60)
  Age (mean/range) 64/36–79
Acute patients (NSTEMI)
  Participants 21 (51)
  Male (% acute patients) 14 (67)
  ‘Treat and send’ patients 10 (47)
  Age (mean/range) 69/40–87
Cardiologists
  Participants 19 (100)
  Operating interventional cardiologists 13 (69)
  Male 14 (75)
  Age (mean/range) 45/30–57
NSTEMI, non-ST elevation myocardial infarction; SCAD stable 
coronary artery disease.
'Treat and send' patients were admitted to a non-PCI centre 
hospital before being transferred to one of the participating 
hospitals for treatment.
reread and all transcripts open coded by JP. The analyt-
ical process was progressed through a series of meetings 
with researchers, health professionals and service 
users. A coding framework was developed which was then 
systematically applied to the corpus of data. Contribu-
tors discussed their own personal views at the meetings 
and how these might influence the analytical process, to 
support reflexivity. A process of constant comparison char-
acterised the analysis22 supported by qualitative software 
(NVivo V.10) to manage and retrieve data. This process 
allowed comparison of the informed consent process, 
behaviour and perceptions of the participants including 
deviant case analysis. The coding process was supported 
by written memos, which underpinned the develop-
ment of higher level codes, themes, categories and the 
resulting core category. The methodology was reported 
using Consolidated Criteria for Reporting Qualitative 
Research (COREQ) criteria (see online supplementary 
material 2).23
FIndIngs
Ninety-eight eligible patients and 22 cardiologists were 
invited to participate. Patient and cardiologist interviews 
lasted an average of 37 minutes and 42 minutes respec-
tively. The pre-PCI consent discussion between patients 
and cardiologists lasted an average of 7 minutes. The 
final sample (see table 1) comprised 41 patients (42% 
response rate) and 19 cardiologists (13 consultant cardi-
ologists and 6 cardiology registrars; 86% response rate). 
Informed consent discussions were audio recorded for 
37 of the 41 patient participants. Thirteen acute patients 
withdrew before interview, nine changed their mind and 
four were not contactable.
We identified three themes and six categories describing 
the role of the informed consent discussion in patients’ 
decisions to have PCI treatment (table 2). These themes 
underpinned an overarching category, "I just want to 
be fixed". In summary, the informed consent discussion 
that took place in hospital did not facilitate partnership 
and supported decision-making. Instead it represented 
a confirmation exercise enabling doctors to encourage 
continued compliance with treatment, and for patients to 
access to treatment.
theMe 1: the InForMed consent experIence
This theme describes how the informed consent process 
takes place. During the discussions, cardiologists delivered 
and patients received information about risks and bene-
fits and checks were made to establish whether patients 
were satisfied with this information. Patients’ experiences 
of the informed consent process varied according to their 
clinical presentation (elective or acute) and the hospital 
they attended, but the decision to have treatment, had 
in most cases, already been made before the discussion 
took place.
category 1: diverse consent journeys
The pattern of service delivery varied by both procedure 
and site but all patients, regardless of acute or elective 
presentation described experiencing the four stages of 
consent shown in figure 1. There were three ‘types’ of 
patient journey: acute (admitted to hospital urgently with 
myocardial infarction and retained on ward for PCI treat-
ment 12–48 hours later) (female acute patient 6, table 2); 
‘treat and send’ (admitted to a non-PCI hospital urgently 
with myocardial infarction and retained on ward until 
transfer to Hospital 1 or  2 for PCI treatment 1–7 days 
later) (male 'treat and send' patient 33, table 2; and elec-
tive (referred to cardiologist by a general practitioner 
(GP) with angina symptoms and referred for elective 
PCI) (interventional cardiologist 3, table 2)
Patients accessing acute PCI treatment had their first 
contact (stage 1: diagnosis, fig 1) with a health profes-
sional either by ambulance, through accident and 
emergency, or were transferred from another hospital in 
the region. Patients had a preliminary consultation in a 
ward setting with a general cardiologist or in a minority 
of elective cases at one hospital, the interventional 
cardiologist, that would conduct the procedure (stage 
2: PCI referral, fig 1) and it was at this consultation that 
the decision to have treatment was made. They were 
given written information about the procedure to read 
and this was followed by ‘detailed information giving 
(stage 3: detailed information giving, fig 1)’ discussion 
2–24 hours later. The recorded discussion took place at 
this point at hospital 1. Practices varied regarding the 
time at which the consent form was signed. This could 
occur either during the in-depth discussion, or when 
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Table 2 Themes and categories
"I just want to be fixed"
Theme 1: the informed consent experience
Diverse consent 
journeys
"When I came to the hospital they told me that I probably had a few small heart attacks. I was given 
information. But to tell you the truth I may have glanced at it. I don’t really know whether I went into it 
with a fine toothcomb but I was aware of it anyway…Before the angioplasty the doctor went through the 
consent form. But the thing is the amount of information that’s fed to you is enough to frighten you to 
death actually. I think maybe it’s a little bit too much" (female acute patient 6, interview).
"Seven days I was waiting at (admittance hospital) before they took me over to (treating hospital) for 
surgery. It was ridiculous, what a waste of money keeping me in, but if they’d have discharged me I would 
have been back of the list. I had some information about angioplasty at (admittance hospital) but signed 
the consent form at (treating hospital) and saw the doctor there just before" (male ‘treat and send’ patient 
33, interview).
"With the elective patients, about six or seven people will have spoken to them about the procedure 
before you stick a needle in them. So they get enough time… slightly less discussion with acute 
coronary syndrome patients because they are in the hospital rather than coming in to clinics as an 
outpatient"  (interventional cardiologist 3, interview discussing elective patient journey).
Information 
transfer
"The most common risks are bruising and bleeding, either from the wrist or from the groin. And usually 
we can just treat that with pressure. Occasionally, we damage the artery and that might need a surgical 
repair. Other problems are, you can be allergic to the dye but we know you had it last time so I don’t think 
you’ll be allergic to it. The dye can cause problems with your kidneys and you have diabetes so you need 
to make sure you’re well hydrated afterwards…"(interventional cardiologist 11, audio recorded consent 
discussion).
"I’m fairly happy and confident in consenting almost all patients who come in for angioplasty, I think 
I’ve assisted and seen quite a few cases, but there are still cases where I might not be able to quote an 
accurate risk, especially in someone who’s undergoing a very risky procedure" (cardiology registrar 2, 
interview).
JP: "Do you think that patients want to know about the risks?"
"Some people will just outright say, ‘I don’t want to know about the risks’. I accept that and say ‘that’s 
fine’…it’s wrong to say you might die, you might have a heart attack, you might have a stroke. They just 
don’t want to know. They will say, ‘right I trust you; you get on and do what you think you need to do’. I 
think that is perfectly reasonable" (interventional cardiologist 6, interview).
"So there are three ways we can treat that. Tablets, heart bypass surgery or angioplasty. It’s not that easy 
to justify a major operation which carries quite a risk and obviously the older you get that risk is just a little 
bit more. So the other two options are either tablets or stents, the angioplasty. Okay. That’s unblocking it 
with the balloons and the stents. I think we could be fair to say the tablets haven’t really worked. From the 
investigation you had last week we know what needs to be done (angioplasty)"(interventional cardiologist 
4, audio recorded consent discussion).
"The only thing was at pre-op assessment I was told about heart attack, a stroke and mortality all in the 
same sentence. I wanted to know what the separate risks for those things…but they didn’t have that 
information…when I got to see doctor X (on the day of the procedure), he got the information straight away 
but that was right before I went in" (male elective patient 9, interview).
Theme 2: role and expectations
‘A formal event’ "We often only interact with the patient on the day of the procedure… by the time they come to 
the catheter lab…somebody should have gone through what we’re doing and why we’re doing it" 
(interventional cardiologist 14, interview).
"Patients usually want to make sure that I’m going to do the procedure or not. In most of the cases 
I’m consenting (completing the consent form) and someone else is doing the procedure so after our 
conversation they will see the consultant who is going to do the procedure and the patient will feel more 
confident about the doctor and they can confirm everything for them" (general cardiologist 7, interview).
"The surgeon came and gave me booklets and wanted me to read them. I said to him, 'Look, do you know 
what you are doing? If you do, just get on with it. I do not want any of this nonsense.' If there was a form to 
sign I signed it, and that was the end of it" (male elective patient 5, interview).
"He probably thinks, "I’ve lived a lot of my life and I've got to this point now without worrying about red 
tape". They often see it as red tape and paperwork. I think he was probably thinking that this was all 
political correctness and red tape but he was thinking "I've got to where I am without bothering about this; 
let’s just get on with it" (interventional cardiologist 1, interview).
Continued
group.bmj.com on July 4, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 5Probyn J, et al. BMJ Open 2017;7:e015127. doi:10.1136/bmjopen-2016-015127
Open Access
"I just want to be fixed"
Expectations of 
treatment
"I decided to have it as soon as doctor X said about it because there was so much pain for me attached to 
the simple things I was doing, walking downhill and so the choice never entered my mind. I was just quite 
happy to go along with what they recommended, you know I just wanted my old life back" (female elective 
patient 21, interview).
"It was a one way street for me and it was going to stop me having another heart attack. I want to stay alive 
and that’s it really" (male acute patient 11, interview).
"I knew what it was all about …he explained it all to me, and I said yes, and I just signed the consent form, 
because I had nothing to worry about if I knew doctor X were there, because I mean he had done it before" 
(male acute patient 15, interview).
"I fully recognised what they were doing and when they didn’t (put a stent in) I was upset because I 
thought they would do it. But we are back to square one and so I have six weeks of these tablets and take 
it from there…but I don’t want a bypass at 80 odd years old" (male elective patient 8, interview).
Theme 3: deciding to have treatment
‘You’re the expert 
doctor
Doctor: Is there anything else you want to ask?
Patient: "It’s really about what I’m going to feel like after it's been done. I need to get back to work, I'm a 
policeman…I've been off since the end of September…so how quickly am I going to be able to get back to 
work, really?
Doctor: "It depends what…how much we do today. So if we get all the arteries open today, then in terms 
of physical activity, I’d be pretty happy for you to return to physical activity almost immediately…." (male 
elective patient 36 and interventional cardiologist 13, audio recorded consent discussion).
"I’m a firm believer in if the medical professional can give me a decent reason, or a reasoned explanation 
for doing something, then I’m quite happy to go along with it. I’ll do a little bit of research…but I’m 
prepared to be guided by what the doctors say. What’s the point in saying no? You’ve got to gulp and get 
on with it, they know best"  (female elective patient 18, interview).
"There was no decision for me to make. The doctors recommended that’s what needed to be done. And 
there’s no point it crossed my mind not to have it, no. Never. The risks do cross your mind but they don’t 
take more than two seconds to weigh up the pros and cons and come out with an answer"(female elective 
patient 22, interview).
A 'Hobson’s 
choice'
‘So if you know there’s risk, you decide either yes to have it done or no. And the thing is you’ve got to have 
it done, so you've got to take the risk"  (male acute patient 20, interview).
"I knew how I was feeling and I couldn’t cope very well with the feelings I was having, getting out of breath 
and things like that. So I thought well I haven't really got an option" (female elective patient 24, interview).
Well,  the decision was made beforehand because doctor X said to me, when I went to see him, he says, 
“We’re going to have a look inside your heart." He says, 'We’ll put a camera in and this, that and the 
other'and I just turned round to him, I says, ''Well, whatever’s got to be done, do it.' You know, there’s no 
choice really. I’d sooner you do it than mess about for four or five months and then come back later. Do it. 
You know, do it straight away, don’t hang about. Just do it, and that’s what they’ve done" (male elective 
patient 10, interview).
Table 2 Continued 
consent was confirmed, just before treatment. Patients 
transferred from non-PCI hospitals (‘treat and send’ 
patients) waited between 1  to 7 days at the admitting 
hospital before a bed was available at the hospital with 
PCI services. The duration of the wait depended on the 
throughput of the hospital providing PCI services. The 
operating cardiologist recapped information immedi-
ately before the procedure and confirmed the patient 
wanted to proceed (stage 4: confirming consent, fig 1). 
The recorded discussion took place here at hospital 2.
Elective patients had a similar ‘journey’ except the 
process took place over a longer period and the settings 
were different. First contact was typically through a GP 
(stage 1: diagnosis, fig 1). Preliminary consultation 
took place in an outpatient setting and it was usually 
at this consultation that the decision to have treatment 
was made (stage 2: PCI referral, fig 1). Following this 
they were sent written information about PCI by post. 
Attendance at a pre-PCI clinic facilitated ‘detailed 
information giving’ (stage 3: detailed information 
giving, fig 1) which could be nurse-led, or doctor-led, 
with the latter including the completion and signing of 
the consent form. The recorded discussion took place 
at this point at hospital 1. As with acute PCI patients, 
the final part of the informed consent process was 
‘confirming consent’ (stage 4: confirming consent, 
fig 1) conducted by the operating cardiologists just 
before treatment. The recorded discussion took place 
at this point at hospital 2. The consent form was signed 
at different stages at the two sites, either at the preop 
assessment, or immediately before the procedure. The 
patient experience from the first point of contact to 
the PCI procedure was thus influenced by a number of 
factors, including the amount of time between referral 
and treatment, the health professionals they had face-
to-face contact with, whether they were admitted to 
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Figure 1 The four-stage informed consent process experienced by acute and elective patients at both hospital sites. Key: 
A&E, accident and emergency; GP, general practitioner; PCI, percutaneous coronary intervention.
a PCI treatment hospital in the first instance and the 
point at which the consent form was signed.
category 2: information transfer
The breadth of risk information given to patients in the 
discussions varied considerably based on cardiologists’ 
judgements about what level of information was appro-
priate or comfortable for them to disclose, the amount 
of time available for the discussion and their knowledge 
of the patient. Most cardiologists balanced the risks of 
the procedure with a statement about the benefits (Inter-
ventional cardiologist 11 , table 2). Some gave patients a 
choice as to whether they wanted the information about 
risk whereas others felt duty-bound to disclose it regard-
less. In one case a patient requested not to be given any 
information about risk and the cardiologist respected this 
choice.
Risk was rarely individualised for patients even when 
they had multiple health conditions or had had previous 
coronary bypass surgery. There was variation in the degree 
of detailed information about risk given to patients (see 
table 3). At hospital 1, the consent forms were pre-printed 
with general risk information. This information was 
provided as it was usual practice for general and registrar 
cardiologists to take consent rather than interventional 
cardiologists. At hospital 2 where interventional cardi-
ologists took consent, cardiologists documented risk 
calculations on the consent form by hand. 
General and registrar cardiologists (those taking 
consent from patients but not performing the inter-
vention) did not always have the specialist knowledge 
required to individualise risk information (cardiologist 
registrar 2 , table 2) and interventional cardiologists were 
constrained by the short amount of time available for the 
discussion, particularly as some conducted the discussion 
immediately before the procedure. Some patients would 
rather not have known about risks (interventional cardi-
ologist 6 , table 2); others wanted to know every detail. 
Some patients, who were admitted acutely, struggled to 
absorb information, probably due to the stress of their 
emergency admission to hospital. In contrast, some elec-
tive patients felt that knowing too much information 
early on in the process caused them anxiety. Most of 
the patients who did not want to know about the risks 
also did not question the doctor’s decision to refer them 
for treatment. Those who did wish to know about the 
risks were more proactive in their decision-making and 
recognised their role in the process. Regardless of the 
mode of delivery and content of the information given, it 
was clear that the value patients placed on the benefits of 
treatment clearly outweighed the risks.
Alternative options for treatment were not usually 
discussed in stage 4 ‘confirming consent’ (fig 1) of 
the informed consent discussions with elective or acute 
patients. When options were mentioned, they were 
acknowledged as potential options to eliminate rather 
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Table 3 Variations in descriptions of risk by two different cardiologists (acute cases). P (patient); C (cardiologist)
Detailed risk description
(female acute patient 19 (P); cardiologist 7 (C):hospital 1)
Less detailed risk description (female acute patient 24 (P); 
cardiologist 15 (C):hospital 2)
C: "On average the risks of stretching an artery and putting a 
stent is about 1% or 2% risk. So one or two people in a 100 of 
us causing a problem, of causing a heart attack. On average 
the sorts of narrowing that we would treat would have a high 
risk of causing a heart attack if we didn’t treat. So there’s 
some risk for the procedure but there is as much or more risk 
without the procedure. There are other risks that I mentioned 
before things like strokes, allergic reactions, kidney problems 
are still very rare. So there’s still less than a 1% likelihood. So 
overall your risk of any major problems, stroke, heart attack, 
life threatening problem and dying from the procedure is very 
unlikely. The risk of us causing a bit of injury to a heart though 
and triggering a heart attack is maybe about 1% or 2%. It’s 
not usually a life changing event but it can happen during the 
procedure. We quote with an angioplasty about a 1 in 1000 
risk of needing a bypass as an emergency. That’s still the case 
for you even though you’ve had a bypass because occasionally 
the catheter might injure the artery and you might need 
something done quite quickly, which might need surgery rather 
than stents. But it is very, very rare and it is 1 in 1000 less that 
needs that.
P: "Okay, yes."
C: "As in any procedure, there is always a risk.
P: "Just …just don’t burst my artery that is all [laughs].
C: "You do know…yes, certainly, you do know one of the risks 
but there are several risks but the risks are very small.
P: "Yes.
C: "So the risks are one, as you said, you can have bleeding 
from either the site, from the groin or from the arm; there is a 
small risk of you having a stroke or a heart attack during the 
procedure, it is very tiny.
P: "Yes.
C: "There is a tiny risk that the contrast that we inject can cause 
impairment of your kidney but that usually recovers in a few 
days with fluids. Very few people are allergic to contrasts, not 
many, but of course the benefit of this thing is tremendous, if 
you do have a blockage. The benefit of doing this procedure is 
tremendous, that is why we go ahead and do it."
than a realistic choice to patients (interventional cardiolo-
gist 4, table 2), indicating that the decision to proceed with 
treatment had already been made. Patients were satisfied 
with the informed consent process, including the amount 
of information they received. This included information 
booklets sent out to elective patients in advance and given 
to acute patients on the ward. Doctors were perceived by 
patients as a collective medical team. Patients were not 
concerned that they saw different health professionals at 
different stages in the process, apart from one incident 
where communication had failed between stages, leaving 
the patient with suboptimal information (male elective 
patient 9, table 2).
theMe 2: roles and expectatIons
The second theme, ‘Roles and expectations’ describes 
how patients and cardiologists define informed consent 
and patients’ expectations of treatment. In all recorded 
consent discussions, doctors were the information givers 
and decision-makers and patients accepted this. This 
was explained in the interview data by the ways in which 
patients and cardiologists defined informed consent 
and their roles within the process (i.e. doctor as expert, 
patient as passive) and their personal contexts that is, 
diagnosis (patients) and role within the cardiology team 
(doctors). Neither cardiologists nor patients defined 
the discussion at which the consent form was signed as a 
decision-making exercise. Rather, it was an opportunity 
for patients to be reassured about the need for treatment 
and for cardiologists to confirm patients’ understanding 
before the procedure.
category 1: a ‘formal event’
Cardiologists defined informed consent as an ongoing 
process supporting patients’ decision-making, and as their 
professional duty. This was based on best practice guidance, 
patient-centred care and self-protection against litigation. 
Interventional cardiologists (those conducting the PCI 
procedure) saw their role as confirming consent with patients 
on the day of the procedure (interventional cardiologist 
14, table 2). General cardiologists and registrars who took 
consent at preop assessment saw their role as taking consent 
on behalf of the operating cardiologist (general cardiologist 
7, table 2). If they lacked expertise in interventional cardi-
ology, they were reassured that consent would be confirmed 
with the patient by the operator on the day of the procedure. 
When interventional cardiologists took consent immediately 
prior to the procedure, having not met the patient before, 
they were forced to make a judgement about the informa-
tion the patient had previously received.
Due to service delivery schedules, most interventional 
cardiologists did not meet patients until the day of the 
procedure (stage 4, fig 1) and there was an assumption 
that the ‘real’ informed consent had occurred prior to this. 
All cardiologists confirmed consent by clarifying patients’ 
understanding, usually by asking the patient if they had any 
questions. Once questions were answered, understanding 
was confirmed. Thus, the discussion during which the 
consent form was signed represented a checking exercise 
rather than supported decision-making between the doctor 
and the patient.
Patients interpreted informed consent as necessary for 
them to access treatment ("red tape") (male elective patient 
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5 and interventional cardiologist 1, table 2) and to protect 
the doctor against litigation. Patients were anxious about 
their health, focused on getting well and felt obliged to 
accept the treatment offered. A small minority of patients 
defined it as a decision-making exercise; in one case 
this was because the patient was given a choice between 
bypass surgery and PCI. Although this patient was given 
adequate information, he was not confident he had made 
the ‘right’ decision, indicating the importance of the 
doctor-patient partnership in decision-making.
category 2: expectations of treatment
Elective and acute patients had different expectations 
of treatment based on the information they had been 
given, although both types of patients focused on the 
outcome of treatment, rather than the treatment itself. 
Elective patients focused on getting ‘back to normal’ 
and improving their quality of life with reduced angina 
symptoms and increased energy (female elective patient 
21, table 2), whereas acute patients focused on staying 
alive and prevention of future heart attacks (male acute 
patient 11, table 2). A small number of patients who had 
undergone previous angiograms, felt reassured and knew 
what to expect (male acute patient 15, table 2). Patients 
were disappointed when their expectations of treatment 
were not achieved, and they were not ‘fixed’; for example 
in two cases where PCI could not be done and other 
options such as a bypass were being explored (male elec-
tive patient 8, table 2).
theMe 3: decIdIng to have treatMent
This theme explains how patients’ perceptions of doctors 
and the availability of medical treatment influenced 
their decisions to have PCI treatment. Patients perceived 
medical authority to override their autonomy for deci-
sion-making and felt obliged to accept National Health 
Service (NHS) treatment recommended to them if they 
had the will to get well. This meant that the informed 
consent discussion was often an information delivery 
exercise rather than a supported decision-making discus-
sion, as the decision had usually been made at the referral 
stage (stage 2, fig 1).
category 1: ‘You’re the expert doctor’
Cardiologists took a leading role in discussions that 
occurred during the signing of the consent form; most 
were short, concise and standardised, with little involve-
ment from the patient. Some lasted as little as 3 minutes 
when occurring immediately prior to the procedure. 
It was unusual for patients to ask questions even when 
prompted by the doctor. Patients who asked questions 
were motivated by contextual factors such as the impact 
of the procedure on caring responsibilities and their 
career (male patient 36 and interventional cardiologist 
13, table 2). Patients distinguished levels of expertise 
between themselves and cardiologists. Most patients felt 
they did not need information about the procedure on 
the basis that they trusted the doctor, and that it was their 
role to listen but not to question (female elective patients 
18 and 22, table 2). Patients and cardiologists valued the 
interaction during the discussion for different reasons. 
For interventional cardiologists it was important to meet 
their patients to develop a ‘rapport’ with them before 
the invasive procedure. For patients, having the proce-
dure explained to them by a doctor was the authority 
confirming that the procedure would be carried out.
category 2: a ‘hobson’s choice’
Patients talked about having a ‘Hobson’s choice’ (a phrase 
describing the choice between accepting or refusing only 
one available option) to make about treatment. This 
was especially prevalent when the patient was told that a 
bypass and/or medication alteration were not options for 
them early on in the informed consent process, or when 
acute patients were told that it was necessary to prevent 
future risks of a heart attack (patients 20, 24 and 10, 
table 2). They acknowledged they were given adequate 
information to make a decision, but ultimately they felt 
that if they wanted to be well again, they had an obli-
gation to accept the treatment recommended to them. 
Thus, most patients made the decision to have treatment 
at stage 2 (referral, fig 1). Interestingly, elective and 
acute patients both felt this, although the outcome of 
the elective procedure was solely symptom improvement 
rather than the prevention of future heart attacks. This 
indicates that when the in-depth discussion and consent 
form signing occurs at stages 3 or 4 (fig 1), the decision 
to have treatment has already been made. Some cardi-
ologists believed that elective patients were more likely 
to have made the decision to have treatment before the 
discussion than acute patients, given the longer duration 
of time they had to consider.
core categorY: ‘I just want to be FIxed’
The informed consent discussion was part of a four-stage 
process of informed consent taking place either at the 
patient’s preop assessment (elective), or immediately 
before the procedure (acute). Patients’ journeys prior 
to the consent discussion involved discussions with a 
range of different health professionals but varied based 
on symptom presentation and the hospital attended. In 
most cases the discussions we recorded did not support 
decision-making as the decision had already been made 
at stage 2 (PCI referral, fig 1). Rather, discussions acted as 
a formal event to check patient understanding for cardi-
ologists and as access to treatment for patients. Patients 
wanted to be ‘fixed’, trusted the medical profession and 
felt obliged to accept the treatment offered. Cardiologists 
(particularly those taking consent immediately before the 
procedure) had rarely met patients prior to the discussion. 
This meant they had limited time with, and knowledge of, 
patients and had to make assumptions about the infor-
mation patients had been given prior to the discussion. 
This was particularly difficult when dealing with ‘treat 
and send’ patients from another hospital as cardiologists 
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were unaware of earlier interactions and discussions they 
may have had. 
In general, patients were passive in decision-making 
during the consent discussions we recorded as they 
believed they had no other choice, trusted medical staff 
to ‘fix’ them and ultimately had already made the deci-
sion to have treatment. This underpins the overall theory 
that the discussions we recorded (when the consent form 
was signed) functioned as a pre-treatment gate-keeping 
exercise for both parties. Such discussions enabled the 
‘fixing’ of the patient but decision-making takes place at 
the earlier 'referral' stage.
dIscussIon
summary
Our findings show that patients had a variety of encoun-
ters with health professionals before meeting the 
operating interventional cardiologist immediately before 
the procedure. Most had already made the decision to 
have treatment by this point after reading written infor-
mation given to them on the ward (acute), or sent to them 
by post (elective), and having had a referral discussion 
with a cardiologist. Patients recognised cardiologists as 
experts and trusted the medical system to ‘fix’ their health 
problem. Most were typically unaware of their role in the 
consent process and had limited autonomy and partici-
pation in the consent discussion that occured when the 
consent form was signed. This informed consent discus-
sion functioned as a formal ‘event’ enabling cardiologists 
to check patients’ understanding and enabling patients 
to access treatment.
strengths and lIMItatIons
This study builds on the limited qualitative research 
available on informed consent for PCI12–14 19 and adds 
a new perspective to current knowledge on this topic 
as earlier studies have largely reflected an American 
viewpoint.9 10 12–14 17 18 Our study is original because of 
the triangulation of data from ‘real’ informed consent 
discussions together with in-depth interviews with partic-
ipants. Our model of the informed consent process adds 
to, and extends on, existing yet dated research,12–14 
and is grounded in the reality of the English practice 
setting. The qualitative nature of the findings may limit 
transferability to other sites but the triangulation of 
methods supports the trustworthiness of the study find-
ings. Informed consent is a universal patient right and a 
process that occurs globally for all invasive procedures. 
Accordingly it is likely that findings will have applica-
tion across other healthcare settings in which informed 
consent is required. We only directly observed one part 
of patients’ informed consent journeys (the signing of 
the consent form) and we relied on patient and cardi-
ologist reports of earlier discussions and the overview 
of the consent process. Furthermore, although this was 
unknown at the time of data collection, the consent 
discussions were recorded at different points in the 
consent journey at the two sites. Thus, further research 
is needed to explore all stages of informed consent to 
determine whether the current service delivery model 
supports patients to make fully informed decisions 
about PCI treatment. Although cardiologists were asked 
to conduct the informed consent discussions as per 
standard practice, the audio recording of consultations 
could affect the nature of the consultation thereby intro-
ducing potential bias.
coMparIson wIth exIstIng lIterature
Our model of the in-hospital informed consent process, 
based on patients’ and cardiologists’ accounts, supports an 
earlier published model.12 However, our findings show that 
the first four stages of Lidz and colleagues' (establishing, 
responsibility, defining the problem, setting goals for treat-
ment and selecting an approach to treatment) take place in 
the PCI referral consultation, and patients made the deci-
sion to have treatment at this point. Given that previous 
research has shown that how cardiologists present infor-
mation has a strong influence on patients’ perceptions of 
PCI treatment,17 18 exploring what happens in these initial 
discussions as part of the informed consent process is vital. 
In the discussions we recorded, alternative options for treat-
ment were rarely mentioned. Although they may have been 
mentioned in previous discussions patients had with other 
health professionals, patients were not always reminded 
of this before signing the consent form. Other evidence 
suggests that PCI patients are not always aware of alternative 
treatments9 and that cardiologists’ perceptions of the bene-
fits of PCI are more optimistic than the evidence available, 
with PCI being the preferred treatment despite prognosis.24
Risk information given to patients was variable across 
discussions as shown elsewhere15 16 but because of its 
placement in this discussion, it did not influence patients’ 
decisions to have treatment. To confirm understanding 
before consent, cardiologists asked patients if they under-
stood the information given and usually gave them the 
opportunity to ask questions. Patients rarely asked ques-
tions and this passive role in decision-making could explain 
why patients in studies of informed consent for various 
surgical procedures often have difficulty recalling infor-
mation.25 26 Passivity in decision-making (ie, feeling they 
had 'no choice’) was underpinned by threatening symp-
toms, angina pain (elective patients) or a (NSTEMI) heart 
attack (acute patients) and a desire to get well. Patients 
had faith in the medical profession to ‘fix’ them, and saw 
PCI treatment as their only option. Other studies have 
reported that patients see PCI as a ‘fix’27 and are somewhat 
reluctant to participate in decision-making discussions. 
Moreover informed consent discussions studied in other 
settings, such as non-emergency surgical procedures have 
been reported to function as an interaction that confirms 
rather than facilitates supported decision-making. .19 When 
patients see only one realistic option in a health decision, 
the collaboration envisioned in the literature on supported 
decision-making is probably unrealistic.28
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IMplIcatIons For research and practIce
Our findings, and others’19 illustrate that service delivery and 
time pressures are key barriers to shared decision-making 
in informed consent discussions. It is concerning that issues 
pertinent 20 years ago in Lidz and colleagues’ research,12–14 
could continue to jeopardise the quality of informed 
consent. Detailed information provided to patients often 
comes after the decision to proceed with treatment has 
been made and the patient has committed to the treatment 
thereby reflecting an ‘event’ rather than a ‘process’ model 
of consent. While this satisfies legal requirements, it does 
not foster supported decision-making.12–14 We have iden-
tified a four-stage consent process underpinning patients’ 
otherwise diverse informed consent experiences. We have 
shown that patients sometimes make decisions to have 
treatment before having an in-depth discussion and that 
risk information varies in presentation across sites. Further 
research is needed to understand the context in which 
these decisions are made at the PCI referral stage, to ensure 
that opportunities for supported decision-making are 
optimised. Educational resources for patients and health 
professionals are needed to raise awareness of their roles in 
supported decision-making. Research has shown that deci-
sion-making processes are improved when practitioners 
are motivated and perceive that it will have an impact on 
the clinical process and patient outcomes.29 This is vital as 
the roles and relationships between doctor and patient can 
shape the behaviours and attitudes of patients, and support 
or discourage them to engage in their healthcare.30
conclusIons
Research has shown that the process of informed 
consent is fraught with limitations regardless of country 
and setting. Informed consent is defined as a process to 
enable patients to make informed decisions about their 
treatment, yet our findings suggest that in the context of 
PCI the process acts as a formal event to check under-
standing and enable access to treatment rather than 
to support decision-making.   Patients' decisions to have 
treatment are largely based on trust and obligation. 
Our process model of informed consent builds on, and 
extends, existing research and indicates that cardiolo-
gists may unintentionally support patients to be passive, 
rather than active, in the decision-making process. The 
configuration of services and patients’ perceptions of 
their role in informed consent underpin a mismatch 
between legal and ethical principles of informed consent 
and current practice. In light of the Montgomery case,8 
the emphasis of informed consent has shifted away from 
doctors’ judgments about what to disclose, to patients’ 
judgments about what they want to know. In a time of 
economic restraint in the NHS we need to find ways, 
through education, to ensure that patients are supported 
to make decisions about their care. A new approach to 
informed consent is required. Educational interven-
tions to support decision making have the potential to 
influence practice internationally. We have focused on 
just one stage of the informed consent process for PCI. 
Further work is needed to explore the link between 
supported decision-making and informed consent 
through all stages of the consent process to identify strat-
egies for service improvement.
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